2,382
Views
6
CrossRef citations to date
0
Altmetric
Short Communication

High diagnostic yield and novel variants in very late-onset spasticity

, , , , , & ORCID Icon show all
Pages 27-32 | Received 09 May 2018, Accepted 21 Dec 2018, Published online: 12 Feb 2019

References

  • Balci, T.B., Hartley, T., Xi, Y., Dyment, D.A., Beaulieu, C.L., Bernier, F.P., … Boycott, K.M. (2017). Debunking Occam’s razor: Diagnosing multiple genetic diseases in families by whole-exome sequencing. Clinical Genetics, 92, 281–289. doi:10.1111/cge.12987
  • Brugman, F., Scheffer, H., Wokke, J.H.J., Nillesen, W.M., de Visser, M., Aronica, E., … van den Berg, L.H. (2008). Paraplegin mutations in sporadic adult-onset upper motor neuron syndromes. Neurology, 71, 1500–1505. doi:10.1212/01.wnl.0000319700.11606.21
  • Chelban, V., Tucci, A., Lynch, D.S., Polke, J.M., Santos, L., Jonvik, H., … Houlden, H. (2017). Truncating mutations in SPAST patients are associated with a high rate of psychiatric comorbidities in hereditary spastic paraplegia. Journal of Neurology, Neurosurgery and Psychiatry, 88, 681–687. jnnp-2017-315796. doi:10.1136/jnnp-2017-315796
  • Choquet, K., Tétreault, M., Yang, S., La Piana, R., Dicaire, M.-J., Vanstone, M.R., … Brais, B. (2016). SPG7 mutations explain a significant proportion of French Canadian spastic ataxia cases. European Journal of Human Genetics: EJHG, 24, 1016–1021. doi:10.1038/ejhg.2015.240
  • Chrestian, N., Dupré, N., Gan-Or, Z., Szuto, A., Chen, S., Venkitachalam, A., … Yoon, G. (2017). Clinical and genetic study of hereditary spastic paraplegia in Canada. Neurology. Genetics, 3, e122. doi:10.1212/NXG.0000000000000122
  • Elleuch, N., Depienne, C., Benomar, A., Hernandez, A.M.O., Ferrer, X., Fontaine, B., … Brice, A. (2006). Mutation analysis of the paraplegin gene (SPG7) in patients with hereditary spastic paraplegia. Neurology, 66, 654–659. doi:10.1212/01.wnl.0000201185.91110.15
  • Errico, A., Ballabio, A., & Rugarli, E.I. (2002). Spastin, the protein mutated in autosomal dominant hereditary spastic paraplegia, is involved in microtubule dynamics. Human Molecular Genetics, 11, 153–163. doi:10.1093/hmg/11.2.153
  • Fonknechten, N., Mavel, D., Byrne, P., Davoine, C.S., Cruaud, C., Bönsch, D., … Hazan, J. (2000). Spectrum of SPG4 mutations in autosomal dominant spastic paraplegia. Human Molecular Genetics, 9, 637–644. doi:10.1093/hmg/9.4.637
  • Gorman, G.S., Pfeffer, G., Griffin, H., Blakely, E.L., Kurzawa-Akanbi, M., Gabriel, J., … Taylor, R.W. (2015). Clonal expansion of secondary mitochondrial DNA deletions associated with spinocerebellar ataxia type 28. JAMA Neurology, 72, 106–111. doi:10.1001/jamaneurol.2014.1753
  • Harding, A.E. (1981). Hereditary “pure” spastic paraplegia: A clinical and genetic study of 22 families. Journal of Neurology, Neurosurgery, and Psychiatry, 44, 871–883. doi:10.1136/jnnp.44.10.871
  • Harding, A.E. (1983). Classification of the hereditary ataxias and paraplegias. Lancet (London, England), 1, 1151–1155.
  • Krüger, S., Battke, F., Sprecher, A., Munz, M., Synofzik, M., Schöls, L., … Biskup, S. (2016). Rare variants in neurodegeneration associated genes revealed by targeted panel sequencing in a German ALS cohort. Frontiers in Molecular Neuroscience, 9, 92. doi:10.3389/fnmol.2016.00092
  • Lee, YJin., Jonson, P.H., Sarparanta, J., Palmio, J., Sarkar, M., Vihola, A., … Udd, B. (2018). TIA1 variant drives myodegeneration in multisystem proteinopathy with SQSTM1 mutations. The Journal of Clinical Investigation, 128, 1164–1177. doi:10.1172/JCI97103
  • Loureiro, J.L., Miller-Fleming, L., Thieleke-Matos, C., Magalhães, P., Cruz, V.T., Coutinho, P., … Silveira, I. (2009). Novel SPG3A and SPG4 mutations in dominant spastic paraplegia families. Acta Neurologica Scandinavica, 119, 113–118. doi:10.1111/j.1600-0404.2008.01074.x
  • Niu, Z., Pontifex, C.S., Berini, S., Hamilton, L.E., Naddaf, E., Wieben, E., … Milone, M. (2018). Myopathy with SQSTM1 and TIA1 variants: Clinical and pathological features. Frontiers in Neurology, 9, 147. doi:10.3389/fneur.2018.00147
  • Pfeffer, G., Gorman, G.S., Griffin, H., Kurzawa-Akanbi, M., Blakely, E.L., Wilson, I., … Chinnery, P.F. (2014). Mutations in the SPG7 gene cause chronic progressive external ophthalmoplegia through disordered mitochondrial DNA maintenance. Brain: A Journal of Neurology, 137, 1323–1336. doi:10.1093/brain/awu060
  • Pfeffer, G., Pyle, A., Griffin, H., Miller, J., Wilson, V., Turnbull, L., … Chinnery, P.F. (2015). SPG7 mutations are a common cause of undiagnosed ataxia. Neurology, 84, 1174–1176. doi:10.1212/WNL.0000000000001369
  • Posey, J.E., Harel, T., Liu, P., Rosenfeld, J.A., James, R.A., Coban Akdemir, Z.H., … Lupski, J.R. (2017). Resolution of disease phenotypes resulting from multilocus genomic variation. The New England Journal of Medicine, 376, 21–31. doi:10.1056/NEJMoa1516767
  • Sánchez‐Ferrero, E., Coto, E., Beetz, C., Gámez, J., Corao, A.I., Díaz, M., … Alvarez, V. (2013). SPG7 mutational screening in spastic paraplegia patients supports a dominant effect for some mutations and a pathogenic role for p.A510V. Clinical Genetics, 83, 257–262. doi:10.1111/j.1399-0004.2012.01896.x
  • Schüle, R., Wiethoff, S., Martus, P., Karle, K.N., Otto, S., Klebe, S., … Schöls, L. (2016). Hereditary spastic paraplegia: Clinicogenetic lessons from 608 patients. Annals of Neurology, 79, 646–658. doi:10.1002/ana.24611
  • van Gassen, K.L.I., van der Heijden, C.D.C.C., de Bot, S.T., den Dunnen, W.F.A., van den Berg, L.H., Verschuuren-Bemelmans, C.C., … van de Warrenburg, B.P. (2012). Genotype-phenotype correlations in spastic paraplegia type 7: a study in a large Dutch cohort. Brain: A Journal of Neurology, 135, 2994–3004. doi:10.1093/brain/aws224